Xoft appoints Carol as CMO
Mark Carol, MD, has joined Xoft, maker of the Axxent electronic brachytherapy system, as chief medical officer.

Carol will focus on development of the current breast and endometrial cancer applications, as well as explore future indications and markets based on the ability to deliver KV energy anywhere in the body, said the Sunnyvale, Calif.-based Xoft.

Carol, who recently received the Ira Sohn Conference Foundation Prize in pediatric oncology for his research on the use of KV x-ray-based radiation therapy, previously served as a consulting medical director for Xoft, the company said.